Gastrointestinal Infections News

New guidelines issued in 2021 stated a preference for fidaxomicin as first-line treatment for Clostridioides difficile infection, despite concerns about its cost.

I completed medical school and internal medicine residency in the years immediately before protease inhibitors against HIV reached the clinic.

An investigational oral microbiome therapeutic was superior to placebo in reducing the risk for recurrent Clostridioides difficile infection among patients with three or more episodes, according to the results of a phase 3 trial.

The ACP has released its first-ever guidelines for diagnosing, managing and preventing recurrence of acute left-sided colonic diverticulitis.

For years, we have been asking you to tell us why you chose a career in infectious diseases, a specialty whose importance has hardly been more apparent. We continue to be captivated by the stories you tell.

We compiled a list of the 10 most-read Healio | Infectious Disease News articles from 2021.

My first infectious diseases paper was published when I was 7 months old. Before I was even capable of creating memories and while I was still crawling, my relationship with infectious diseases was off and running.

Stories that focused on emerging research and breaking news related to COVID-19 dominated headlines in 2021.

The front page of Infectious Disease News was dominated this year by stories about COVID-19 and its impact on health care.

In this video, C. Jonathan D. Foster, DO, FACOI, discusses results from the PRISM3 trial assessing CP101, an investigational microbiome therapeutic, for recurrent Clostridioides difficile infection.